7-150951629-G-C
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000238.4(KCNH2):c.1764C>G(p.Asn588Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N588D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1764C>G | p.Asn588Lys | missense_variant | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Short QT syndrome type 1 Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.N588K variant (also known as c.1764C>G), located in coding exon 7 of the KCNH2 gene, results from a C to G substitution at nucleotide position 1764. The asparagine at codon 588 is replaced by lysine, an amino acid with similar properties. This alteration has been reported in individuals with short QT syndrome (SQTS) (Brugada R et al. Circulation, 2004 Jan;109:30-5; Hong K et al. J Cardiovasc Electrophysiol, 2005 Apr;16:394-6; Akdis D et al. Europace, 2018 Jun;20:f113-f121). In multiple assays testing KCNH2 function, this variant showed functionally abnormal results (Brugada R et al. Circulation, 2004 Jan;109:30-5; Grunnet M et al. Cell Physiol Biochem, 2008 Dec;22:611-24; McPate MJ et al. J Physiol Pharmacol, 2009 Mar;60:23-41; Adeniran I et al. PLoS Comput Biol, 2011 Dec;7:e1002313). In addition, a different alteration located at the same position, resulting in the same protein change, c.1764C>A (p.N588K), has been detected in individuals with SQTS (Brugada R et al. Circulation, 2004 Jan;109:30-5; Suzuki H et al. Pediatr Int, 2014 Oct;56:774-6). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic for KCNH2-related SQTS; however, its clinical significance for KCNH2-related long QT syndrome is uncertain. -
Short QT syndrome Other:1
This variant has been reported as associated with Short QT syndrome in the following publications (PMID:14676148;PMID:15828882;PMID:19088443;PMID:19439805;PMID:19501051;PMID:22194679). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at